Foxing Rivals; Fratricidal Manipur; Lensing Prescriptions
Opinion Watch
Foxing Rivals
The Asian Age in its Editorial has claimed that Telangana Chief Minister K. Chandrashekhar Rao (KCR) has created a flutter in New Delhi and other places with his timing of release of candidates’ lost for Assembly elections. The daily argued that “his decision to contest from two seats and retaining most candidates when there are reports of clearly irreversible anti-incumbency of high order against nearly a third, if not half, of his sitting MLAs” are reasons for creating political flutter. It added that Bharath Rashtra Samithi (BRS) is aiming for an unprecedented hat-trick.
KCR is seeking to fox rivals by denying them opportunity to lay hands on BRS MLAs if they were denied nominations in the poll. Also, he is at ease with the Opposition still not in shape in Telangana.
Fratricidal Manipur
The Hindu in its Editorial has come down hard on the civil society in Manipur for failing to rise to the occasion to help douse the fire in the states. “The events in Manipur so far suggest that the ethnic conflict festers because of the intractable positions by the Meitei and Kuki-Zo leaders. The Meitei refuse to acknowledge the sense of bias in the State government’s actions — especially by Chief Minister N. Biren Singh — that have alienated the Kuki-Zo and its representatives, cutting across party lines. The latter seeks to harp on the idea of a “separate administration”, complicating the fragile co-existence of ethnic identities in the State which include others such as the Naga community,” noted the Chennai-based daily.
When civil society remains fractured, the administration must rise to the occasion by enforcing rule of law with firm hand without any bias against any. On that count, the Centre and the incumbent Manipur government are surely in the dock.
Lensing Prescriptions
The Telegraph in its Editorial has faulted the new rules notified by the National Medical Commission, requiring all registered medical practitioners to prescribe drugs by their generic names. “If a medical practitioner prescribes a generic drug, in most cases, the brand will be chosen by chemist shops that are not duty-bound to keep the best interests of the patients at heart. Second, the lack of standardised testing and approval procedures compromises the reliability of generic drugs. An error in noting down the generic names may prove fatal,” argued the Kolkata-based daily.
The overall objective of rules is to break the unholy ties of doctors and pharma companies, and a few irritants shouldn’t come in the way to push ahead. Indeed, the rough edges can be ironed out with firmness and tech-play.
About The Author
